Eton Pharmaceuticals price target raised to $37 from $35 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Eton Pharmaceuticals (ETON) to $37 from $35 and keeps a Buy rating on the shares. The firm says the broader label expands Desmoda’s total addressable market.